•Multicenter Evaluation of the First Validated German-Language Fatigue Questionnaire for Patients with Chronic Inflammatory Bowel Diseases
•Effectiveness and Safety of Advanced Combination Treatment (ACT) in patients with refractory inflammatory bowel disease or concomitant immune mediated disease or extra-intestinal manifestations: A Multi-Center Canadian Study
•The intestinal mucosa-associated microbiota in IBD-associated arthritis displays lower relative abundance of Roseburia intestinalis
•Oral health in inflammatory bowel disease: the overlooked impact and the potential role of salivary calprotectin
•Uncovering shared genetic features between inflammatory bowel disease and systemic lupus erythematosus